[Funding-Opportunities-L] New Funding Opportunities

Funding opportunity announcements. (Mostly non-NIH). funding-opportunities-l@mailman.ucsd.edu
Mon Mar 5 16:11:43 PST 2012


Sponsor:          Bill and Melinda Gates Foundation
Program:          Development of a Rapid Immunity Assessment Tool
Deadline:          March 27, 2012 (Letters of Inquiry)*


Brief Description:

The Bill & Melinda Gates Foundation is now accepting Letters of Inquiry for the development of an easy-to-use tool that rapidly assesses the immune status of children against select vaccine-preventable diseases. Inquiries will be welcome that focus on prototype development and detail plans for future commercialization possibilities. Applicants can be at any experience level; in any discipline; and from any organization, including colleges and universities, government laboratories, research institutions, non-profit organizations and for profit companies. The Gates Foundation is focused on ensuring that all children in the developing world receive a full complement of available vaccines, protecting them against a range of vaccine-preventable diseases. The Foundation endorses and strives for the goal outlined by the Global Immunization Vision and Strategy (GIVS)<http://www.who.int/immunization/givs/en/index.html>, of at least 90% vaccination coverage in every country, and at least 80% coverage in every district.

Contact:                                    gh.immunity@gatesfoundation.org<mailto:gh.immunity@gatesfoundation.org>

Additional information:              Gates Foundation Vaccines PDF<http://www.gatesfoundation.org/vaccines/Documents/rfp-immunity-assessment.pdf>

                                                Gates Foundation DRIA Tool<http://www.gatesfoundation.org/vaccines/Pages/rfp-immunity-assessment-tool.aspx>


Pre-Award Announcement
Sponsor:          Department of Defense (DOD)
Program:          Defense Appropriations Act/Peer Reviewed Medical Research Programs (PRMRP)


Brief Description:

The PRMRP challenges the scientific and clinical communities to address one of the FY12 congressionally directed topic areas with original ideas that foster new directions in basic science and translational research; novel product development leading to improved therapeutic or diagnostic tools; or clinical trials that address an immediate clinical need. This program is administered by the U.S. Army Medical Research and Materiel Command through the Office of the Congressionally Directed Medical Research Programs (CDMRP). The FY12 PRMRP  solicits research applications for the following 22 topic areas: Arthritis, Composite Tissue Transplantation, Dystonia, Drug Abuse, Epilepsy, Food Allergies, Fragile X Syndrome, Hereditary Angioedema, Inflammatory Bowel Disease, Interstitial Cystitis, Listeria Vaccine for Infectious Disease, Lupus, Malaria, Nanomedicine for Drug Delivery Science, Neuroblastoma, Osteoporosis and Related Bone Disease, Paget's Disease, Polycystic Kidney Disease, Post-Traumatic Osteoarthritis, Scleroderma, Tinnitus, and Tuberculosis.

Relevance to the health care needs of the military service members, veterans, and beneficiaries is a key feature of each FY12 PRMRP award mechanism.

Contact:                       CDMRP Public Affairs
301-619-9783
CDMRP.PublicAffairs@amedd.army.mil<mailto:CDMRP.PublicAffairs@amedd.army.mil>
Additional Information:  PRMRP<http://cdmrp.army.mil/>

Sponsor:          Keio University Medical Science Fund
Program:          Keio Medical Science Prize 2012
Prize:                Certificate of Merit, Medal, and Monetary Award
Deadline:          March 21, 2012

Brief Description:

The Keio Medical Science Prize gives recognition to the outstanding and creative achievements of researchers in the fields of medicine and life sciences, in particular those contributing to scientific developments in medicine. It aims to promote worldwide advances in medicine and life sciences, to encourage the expansion of researcher networks throughout the world, and to contribute to the well-being of humankind. Nominees must be currently active in their field of research and must have made an outstanding contribution to clinical medicine. The Keio Medical Science Prize is an international award.


Contact:                        Keio University Medical Science Fund
35 Shinanomachi, Shinjuku-ku
Tokyo 160-8582, Japan
Tel: +81-3-5363-3609
Fax: +81-3-5363-3507
Additional Information:  Keio Medical Science Prize 2012<http://www.ms-fund.keio.ac.jp/prize/index.html>



Sponsor:          Sanofi US Innovation Challenge
Program:          Sanofi US Data Design Diabetes Innovation Challenge
Award:              See below*
Deadline:          March 23, 2012


Brief Description:
Sanofi US believes combining Data, Diabetes, and Design will impact our nation's wellness significantly. The global health care provider is sponsoring an open innovation challenge combating the diabetes epidemic by integrating open data with a human-centered view into diabetes epidemic. Building on the spirit of a code-a-thon, Sanofi US has created a challenge that casts the widest net for data-informed diabetes solutions, culls the best interventions, and incubates the strongest ideas. This challenge is structured to drive entrepreneurship and innovation. The best and most human-centered ideas will be mentored by industry leaders, and all intellectual property and equity will remain the property of its creators. Total awards top $200k, and invaluable support will be provided for game-changing solutions.
Awards:
5 semi-finalists:
$20,000 for development of the concept prototype
Intensive mentorship from industry leaders to hone the concept
Participation in a design boot camp
2 finalists:
$10,000 to create a community-based proof-of-concept program
1 winner:
$100,000 to develop their solution

UCSD Contacts:                        Williams S. Ettouati, PharmD
Director, Industrial Relations & Development Health Sciences Associate Clinical Professor, N.S.
Skaggs School of Pharmacy and Pharmaceutical Sciences
Cell: 858-699-5489
wettouati@ucsd.edu<https://mail.ucsd.edu/owa/redir.aspx?C=4eb0a51e082041c0b21435584e865449&URL=mailto%3awettouati%40ucsd.edu>

Andrew Wiseman PhD
Corporate Business Development Officer
UC San Diego Health Sciences
Phone: 858-822-1706
Cell: 858-922-6795
anwiseman@ucsd.edu<mailto:anwiseman@ucsd.edu>


Additional Information:              Data Design Diabetes Challenge<http://www.datadesigndiabetes.com/rules>



Joint Sponsors:            Sanofi and Institut Pasteur
Program:                      Sanofi - Institut Pasteur Award
Award:                          120,000 Euros ($158,475 US dollars)
Deadline:                      April 20, 2012

Brief Description:

Sanofi, a global diversified healthcare leader and the Institut Pasteur, an internationally renowned biomedical research centre, jointly announce the creation of the Sanofi - Institut Pasteur Awards to recognize scientists for their past or ongoing research demonstrating real scientific progress in the life sciences.

The Sanofi - Institut Pasteur Awards will be given to four scientists for outstanding research in the following subjects:


§   Tropical and neglected diseases


§   Innovative vaccines


§   New approaches to drug resistance


§   Therapeutic approaches to senescence: immunobiology, neurobiology and regenerative medicine



UCSD Contacts:            Williams S. Ettouati, PharmD
Director, Industrial Relations & Development Health Sciences Associate Clinical Professor, N.S.
Skaggs School of Pharmacy and Pharmaceutical Sciences
Cell: 858-699-5489
wettouati@ucsd.edu<https://mail.ucsd.edu/owa/redir.aspx?C=4eb0a51e082041c0b21435584e865449&URL=mailto%3awettouati%40ucsd.edu>

Andrew Wiseman PhD
Corporate Business Development Officer
UC San Diego Health Sciences
Phone: 858-822-1706
Cell: 858-922-6795
anwiseman@ucsd.edu<mailto:anwiseman@ucsd.edu>


Additional Information:  http://www.sanofi-institutpasteur-awards.com<http://www.sanofi-institutpasteur-awards.com/>




Sponsor:          Novo Nordisk Diabetes R&D
Program:          The Novo Nordisk Diabetes Innovation Award Program
Award:              $125,000 (Early Exploration Award)
                        $250,000 (Proof of Principle Award)
Deadline:          August 1, 2012

Brief Description:


Novo Nordisk Diabetes R&D offers a research award program to support both new and established scientists exploring novel hypotheses involving protein-based therapeutics and technologies for diabetes and obesity. The aim of this new research award program is to help scientists substantiate early innovation research efforts and clarify if their hypotheses has the potential to result in the cure, prevention or improved treatment of diabetes and obesity.



The award program scope includes novel research ideas that despite having potentially high impact would not normally attract funding from such institutions as the National Institutes of Health. Under the new program, Novo Nordisk offers two types of research funding opportunities; "Early exploration" or "Proof of Principle" Awards. Both awards can support research projects for up to two years.



Annual Request for Proposals solicits research proposals encompassing biologics (protein-based) research within the following research areas:



§  Obesity and diabetes (all types) research including microvascular complications



§  All aspects of prevention, treatment and cure



§  New biological ligands and targets discovery



§  Novel effects of known proteins



Proposals and questions should be directed to:

:           Williams S. Ettouati, PharmD
Director, Industrial Relations & Development Health Sciences Associate Clinical Professor, N.S.
Skaggs School of Pharmacy and Pharmaceutical Sciences
Cell: 858-699-5489
wettouati@ucsd.edu<https://mail.ucsd.edu/owa/redir.aspx?C=4eb0a51e082041c0b21435584e865449&URL=mailto%3awettouati%40ucsd.edu>


Website:                       Novo Nordisk Diabetes Inno Award<http://www.novonordisk-us.com/documents/promotion_page/document/diabetes_innovation_awards.asp>


Sponsor:          The John Merck Fund
Program:          Developmental Disabilities Translational Research Program
Amount:            $250,000 per year for four-years
Deadline:          May 15, 2012

Brief Description:


The Developmental Disabilities Translational Research Program will support researchers in developing treatments and improving outcomes for individuals with developmental disabilities, particularly Down syndrome and Fragile X syndrome (and FX associated disorders).  The awards will be made to the most highly innovative translational research projects that have the greatest potential of investigating rational and effective treatments and interventions for the particular condition being addressed. The program will emphasize interdisciplinary collaborative grant applications focused primarily on FXS and DS, but the program will support studies focused on other developmental disabilities under special circumstances. The Fund is particularly interested in translational research that is designed to improve the lives of people with developmental disabilities and their families. The Translational Research Program competition accepts applications through a two-part, open process. Investigators from a range of disciplines are encouraged to apply.

Applicants must have the following:

Academic rank in a university or medical school, or equivalent standing in a research institute or medical center

A record of research in areas relating to developmental disabilities
Evidence of a scholarly commitment to a career in developmental disabilities research


Contact:                        Nancy Stockford
            nstockford@jmford.org<mailto:nstockford@jmford.org>


Additional Information:  http://www.jmfund.org/TranslationalResearchProgram.php



-------------- next part --------------
An HTML attachment was scrubbed...
URL: http://mailman.ucsd.edu/pipermail/funding-opportunities-l/attachments/20120306/23847e83/attachment-0001.html 
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image003.png
Type: image/png
Size: 167 bytes
Desc: image003.png
Url : http://mailman.ucsd.edu/pipermail/funding-opportunities-l/attachments/20120306/23847e83/attachment-0001.png 


More information about the Funding-Opportunities-L mailing list